老虎證券
Invest
Pricing
Rewards
Support
About
Quotes
TigerAI
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
LANGAR GLOBAL HEALTHTECH ETF
9.96
-0.0909
-0.90%
盤後:
10.00
0.0342
+0.34%
16:10 EDT
成交量:
4,360
成交額:
4.36萬
市值:
229.10萬
市盈率:
- -
高:
10.02
開:
10.02
低:
9.96
收:
10.05
52周最高:
11.01
52周最低:
7.97
股本:
23.00萬
流通股本:
23.00萬
量比:
1.83
換手率:
1.90%
股息:
- -
股息率:
- -
每股收益(LYR):
1.91
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
5.22
資料載入中...
總覽
公司
新聞資訊
公告
全球首個腦機接口醫療器械標準落地!國內產業邁入規範化黃金期
中金财经
·
09/14
每日特惠-併購
路透中文
·
09/14
康泰醫學:獲得兩項醫療器械註冊證
智通财经
·
09/14
樂高科技、艾迪爾等35家藥企涉商業賄賂,登上貴州醫保基金失信企業「黑榜」
蓝鲸财经
·
09/14
「超30家藥企長期行賄」,涉案醫院回應
澎湃新闻
·
09/14
GE HealthCare (GEHC.US)擬10億美元收購 Sofie,劍指放射性藥物高增長賽道
智通财经
·
09/14
據《金融時報》報道,GE醫療正就收購Sofie Biosciences一事進行談判,交易金額可能達10億美元
路透中文
·
09/13
河北一醫院工作人員先後收受商業賄賂46次,單次最大涉案金額1658萬元,持續時間最長達11年,累計涉案金額1.84億元
大象新闻
·
09/13
凱利泰子公司艾迪爾涉商業賄賂:被列為「特別嚴重失信」企業,集採衝擊、渠道失控兩頭擠壓
蓝鲸财经
·
09/12
Moderna Inc(MRNA)股票9月11日盤中上漲8.63%:關鍵驅動因素揭曉
TradingKey中文
·
09/12
貝泰妮:注射用透明質酸鈉溶液獲得醫療器械註冊證
智通财经
·
09/11
東方生物:獲得多項境外醫療器械註冊證
智通财经
·
09/11
九強生物:取得I型膠原氨基端延長肽測定試劑盒醫療器械註冊證
智通财经
·
09/11
麥科田赴港上市:併購拼出的醫療器械版圖,暗藏多重隱憂
新浪证券
·
09/11
港股異動 | 先健科技(01302)升逾3% LantvalTM主動脈瓣膜置換系統進入創新醫療器械特別審查程序
智通财经
·
09/11
【券商聚焦】中信建投:醫療器械板塊業績有望逐步改善
金吾财讯
·
09/11
深港攜手拓全球藥械市場,2026深圳國際高性能醫療器械展舉行
格隆汇
·
09/11
透景生命(300642.SZ)控股子公司申報醫療器械註冊獲得受理
智通财经
·
09/10
直覺外科高管:海外系統租賃費率將隨時間逐步上調
美股速递
·
09/09
直覺外科高管:美國減重手術僅佔全球達芬奇手術量逾2%,增量影響正逐步放緩——電話會議紀要
美股速递
·
09/09
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/LGHT/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"LGHT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LGHT\",,,,,undefined,":{"symbol":"LGHT","market":"US","secType":"STK","nameCN":"LANGAR GLOBAL HEALTHTECH ETF","latestPrice":9.9608,"timestamp":1789761600000,"preClose":10.0517,"halted":0,"volume":4360,"hourTrading":{"tag":"盘后","latestPrice":9.995,"preClose":9.9608,"latestTime":"16:10 EDT","volume":6,"amount":59.7648,"timestamp":1789762204061,"change":0.0342,"changeRate":0.003433,"amplitude":0},"delay":0,"changeRate":-0.009043246416029082,"floatShares":230000,"shares":230000,"eps":0,"marketStatus":"休市中","change":-0.0909,"latestTime":"09-18 16:00:00 EDT","open":10.018,"high":10.018,"low":9.96,"amount":43578,"amplitude":0.00577,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"exchange":"CBOE","adjPreClose":10.0517,"sharesOutstanding":400000,"nav":10.0444,"aum":2310212.36,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":9.995,"preClose":9.9608,"latestTime":"16:10 EDT","volume":6,"amount":59.7648,"timestamp":1789762204061,"change":0.0342,"changeRate":0.003433,"amplitude":0},"volumeRatio":1.8256426670445245},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LGHT\",,,,,undefined,":{"symbol":"LGHT","floatShares":230000,"roa":"--","roe":"--","lyrEps":1.906946,"volumeRatio":1.8256426670445245,"shares":230000,"dividePrice":0,"high":10.018,"amplitude":0.00577,"preClose":10.0517,"low":9.96,"week52Low":7.97,"pbRate":"--","week52High":11.01,"institutionHeld":0,"latestPrice":9.9608,"eps":0,"divideRate":0,"volume":4360,"delay":0,"ttmEps":0,"open":10.018,"prevYearClose":10.0748,"prevWeekClose":9.7424,"prevMonthClose":10.2195,"prevQuarterClose":8.5377,"fiveDayClose":9.7424,"twentyDayClose":10.06,"sixtyDayClose":8.1921},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LGHT\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LGHT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LGHT\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LGHT\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667668562","title":"全球首個腦機接口醫療器械標準落地!國內產業邁入規範化黃金期","url":"https://stock-news.laohu8.com/highlight/detail?id=2667668562","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667668562?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 18:50","pubTimestamp":1789383002,"startTime":"0","endTime":"0","summary":"9月14日,国家药监局批准发布我国第三个脑机接口医疗器械标准,也是全球第一个采用人工智能技术处理脑电数据的脑机接口医疗器械产品标准,新标准将于明年9月1日起正式实施。业内人士表示,国家药监局采用快速程序立项和标准,新标准为脑机接口医疗器械的研发生产提供了统一的脑电数据集的“质量标尺”,达到国际领先水平。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/14/20260914306536.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/14/20260914306536.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260914/32369354.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["DULL","GBUG","BAR","CEF","02840","SGOL","GDXU","GLTR","DUST","GDXJ","LGHT","FAAR","GLL","XME","DZZ","GOLY","SHNY","MGCmain","GOAU","GDXY","GDOC","AGNG","PICK","1OZmain","HART","09996","IAUI","IBRN","MEDX","IEIH","AAAU","UGL","OUNZ","USG","JNUG","UYM","PHYS","GDX","BEGS","GDXD","PTH","MDEV","GLDM","IAU","159883","GCmain","IAUM","PALL","RSPH","159831"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667065755","title":"每日特惠-併購","url":"https://stock-news.laohu8.com/highlight/detail?id=2667065755","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667065755?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 18:10","pubTimestamp":1789380603,"startTime":"0","endTime":"0","summary":"每日特惠-并购路透9月14日-截至周一GMT0930,已报道以下收购要约、合并、收购和资产处置:** 交易所文件显示,美国私募股权公司KKR已将其持有的菲律宾电力生产商First Gen全部股权以约257.7亿比索的价格出售。此前数周,该公司母公司曾拒绝了KKR增持股份的提议。这家炸药和弹药制造商正寻求拓展其全球采矿业务。nL4N4560EB** 德国Uniper公司表示,已同意出售其持有的Opal天然气管道20%的股权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL4S4560O5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128525689.USD","BK4585","BK4170","BWIN","DELL","LU0211326839.USD","LU1804176565.USD","LU0124676726.USD","WLDR","LU0345770993.USD","LU1235294995.USD","LU2065171402.SGD","BK4535","LU0267386448.USD","BK4173","LU0211326755.USD","LU0976567544.SGD","FXL","LU1267930227.SGD","LU0052756011.USD","DLLL","BK4082","BK4515","BK4543","BK4588","LU1823568750.SGD","LU2265009873.SGD","LU0689626769.HKD","LU0345770308.USD","LU2065170008.USD","GEHC","LU0310800965.SGD","LU1046421795.USD","LU2065169927.USD","LU2065171311.SGD","LU0496365809.HKD","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667659094","title":"康泰醫學:獲得兩項醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2667659094","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667659094?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 16:44","pubTimestamp":1789375491,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LNGR","MDEV","PTH","RSPH","HART","GDOC","LGHT","IEIH","MEDX","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667536746","title":"樂高科技、艾迪爾等35家藥企涉商業賄賂,登上貴州醫保基金失信企業「黑榜」","url":"https://stock-news.laohu8.com/highlight/detail?id=2667536746","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667536746?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 14:51","pubTimestamp":1789368717,"startTime":"0","endTime":"0","summary":"根据公告,对于配送企业,根据信用评价结果限制或中止配送企业在贵州省的配送资格1-5年;对于生产企业,除提醒告诫、提示风险外,限制或中止相关涉案产品或全部产品挂网、投标资格。据悉,贵州省医保基金运行服务中心给出了修复信用评级的方法。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1789368658648386760","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LGHT","MDEV","BK1574","MEDX","09996","IEIH","HART","BK1583","RSPH","AGNG","BK1100","GDOC","LNGR","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667863208","title":"「超30家藥企長期行賄」,涉案醫院回應","url":"https://stock-news.laohu8.com/highlight/detail?id=2667863208","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667863208?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 11:36","pubTimestamp":1789356960,"startTime":"0","endTime":"0","summary":"澎湃新闻首席记者 李潇潇9月13日,国家医保局发布《医疗机构涉医药购销商业贿赂案》一文提到,仅2025年下半年,河北医科大学第二医院就涉及9件司法刑事判决。在国家医保局9月13日最新披露的信息中,有超过30家医药企业长期对河北医科大学第二医院工作人员行贿。具体到河北祥恩医疗器械贸易有限公司一家,该公司为向河北医科大学第二医院销售价格虚高的医疗耗材,累计向该医院工作人员行贿2064万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-09-14/doc-iniruhxa7301443.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-14/doc-iniruhxa7301443.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1100","BK1574","GDOC","09996","HART","LNGR","RSPH","AGNG","IEIH","PTH","LGHT","BK1583","MDEV","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667631088","title":"GE HealthCare (GEHC.US)擬10億美元收購 Sofie,劍指放射性藥物高增長賽道","url":"https://stock-news.laohu8.com/highlight/detail?id=2667631088","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667631088?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 10:25","pubTimestamp":1789352700,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,据知情人士透露,GE HealthCare Technologies正就以约 10 亿美元收购 Sofie Biosciences 进行深入谈判,此举将扩大其在医学扫描所用放射性诊断药物领域的布局。对投资者而言,主要问题在于 GE HealthCare 支付的价格是否合理,以及 Sofie 能以多快速度将其研发管线转化为具有商业意义的销售额。若这笔收购达成,将成为 GE HealthCare 自 2023 年 1 月从通用电气分拆以来的第二笔重大收购。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495467.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"GE HealthCare (GEHC.US)拟10亿美元收购 Sofie,剑指放射性药物高增长赛道","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4082","GEHC","LU0124676726.USD","BK4585","LU0689626769.HKD","LGHT","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667843696","title":"據《金融時報》報道,GE醫療正就收購Sofie Biosciences一事進行談判,交易金額可能達10億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667843696","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667843696?lang=zh_tw&edition=fundamental","pubTime":"2026-09-13 18:10","pubTimestamp":1789294210,"startTime":"0","endTime":"0","summary":"据《金融时报》报道,GE医疗正就收购Sofie Biosciences一事进行谈判,交易金额可能达10亿美元路透9月13日-据《金融时报》周日援引知情人士的话报道,通用电气医疗技术公司(GE HealthCare Technologies,GEHC.O)正在就一笔可能价值10亿美元的交易进行谈判,拟收购放射性药物开发商索菲生物科学公司(Sofie Biosciences)。路透无法立即证实这一报道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260913:nL4S455029:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","LGHT","GEHC","LU0124676726.USD","LU0689626769.HKD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667683005","title":"河北一醫院工作人員先後收受商業賄賂46次,單次最大涉案金額1658萬元,持續時間最長達11年,累計涉案金額1.84億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667683005","media":"大象新闻","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667683005?lang=zh_tw&edition=fundamental","pubTime":"2026-09-13 09:18","pubTimestamp":1789262280,"startTime":"0","endTime":"0","summary":"继上海某科贸商行涉支架球囊行贿案公开曝光河北医科大学第二医院“每条支架收5000元回扣”后,仅2025年下半年,该院又涉及9件司法刑事判决。该医院工作人员先后收受商业贿赂46次,单次最大涉案金额1658万元,持续时间最长达11年,累计涉案金额1.84亿元。分析发现,超过30家医药企业长期对该医院工作人员行贿。河北祥恩医疗器械贸易有限公司为向河北医科大学第二医院销售价格虚高的医疗耗材,累计向该医院工作人员行贿2064万元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-13/doc-inirrtkk4766738.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","IEIH","MEDX","BK1515","RSPH","LNGR","PTH","HART","09996","09939","LGHT","MDEV","BK1161","BK1100","AGNG","BK1583","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666504386","title":"凱利泰子公司艾迪爾涉商業賄賂:被列為「特別嚴重失信」企業,集採衝擊、渠道失控兩頭擠壓","url":"https://stock-news.laohu8.com/highlight/detail?id=2666504386","media":"蓝鲸财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666504386?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 21:10","pubTimestamp":1789218656,"startTime":"0","endTime":"0","summary":"蓝鲸新闻向凯利泰方面求证具体涉案信息,截至发稿尚未收到回复。通过检索公开权威信息发现,除了此次事件,近年来,艾迪尔屡次被曝涉嫌商业贿赂。艾迪尔母公司凯利泰同样多次涉及商业贿赂事件。因为一旦被评定为“特别严重失信”,很可能会失去医保报销市场,对企业发展会带来巨大冲击。不过目前来看,作为名单中7家被评为“特别严重失信”的企业之一,艾迪尔尚未发表致歉声明。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1789198644422913532","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["300326","PTH","MDEV","BK1583","RSPH","BK1100","09996","BK1574","HART","IEIH","AGNG","GDOC","MEDX","LGHT","LNGR","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666657657","title":"Moderna Inc(MRNA)股票9月11日盤中上漲8.63%:關鍵驅動因素揭曉","url":"https://stock-news.laohu8.com/highlight/detail?id=2666657657","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666657657?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 01:16","pubTimestamp":1789146984,"startTime":"0","endTime":"0","summary":"• 受机构买盘重新涌入及盘整巩固的推动,莫德纳出现上行波动。\n• intismeran autogene 的 3 期临床试验结果验证了其肿瘤学平台。\n• 最新年度营收为 19.4 亿美元,净亏损为 28.2 亿美元。","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262164048-market-movers-mrna-20260911","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4551","LGHT","BK4532","MRNA","BK4534","MRNY","MRNX","BK4533","BK4548","BK4501","BK4588","IDNA","BK4585","BK4568","GNOM","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666525651","title":"貝泰妮:注射用透明質酸鈉溶液獲得醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2666525651","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666525651?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 18:17","pubTimestamp":1789121838,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MEDX","IEIH","PTH","MDEV","GDOC","AGNG","LNGR","RSPH","LGHT","HART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666230575","title":"東方生物:獲得多項境外醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2666230575","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666230575?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 18:05","pubTimestamp":1789121126,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["RSPH","HART","PTH","GDOC","MEDX","MDEV","LGHT","AGNG","IEIH","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666544799","title":"九強生物:取得I型膠原氨基端延長肽測定試劑盒醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2666544799","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666544799?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 15:50","pubTimestamp":1789113020,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AGNG","LNGR","MEDX","MDEV","PTH","IEIH","LGHT","HART","GDOC","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666938544","title":"麥科田赴港上市:併購拼出的醫療器械版圖,暗藏多重隱憂","url":"https://stock-news.laohu8.com/highlight/detail?id=2666938544","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666938544?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 15:35","pubTimestamp":1789112100,"startTime":"0","endTime":"0","summary":"近日,麦科田正式开启港股全球发售。盈利脆弱性在 2026 年一季度进一步暴露,上市前夕再度出现 252.7 万元亏损。靠并购快速拼出业务版图的麦科田,即将站上港股资本市场。对于麦科田而言,如何完成并购资产的深度整合、夯实自主研发实力、化解商誉与渠道危机,将决定它能否从并购拼凑的企业,蜕变为具备内生竞争力的医疗器械公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-09-11/doc-inirmvzx5385233.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1583","KCE","RSPH","BK4585","LNGR","IEIH","02041","BK4588","BK1100","159883","09996","BK1574","HART","MEDX","CALF","GDOC","PTH","LGHT","AGNG","XMMO","MYLD","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666517543","title":"港股異動 | 先健科技(01302)升逾3% LantvalTM主動脈瓣膜置換系統進入創新醫療器械特別審查程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2666517543","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666517543?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 09:49","pubTimestamp":1789091380,"startTime":"0","endTime":"0","summary":"消息面上,先健科技发布公告,于2026年9月9日,本公司收到国家药品监督管理局的正式书面通知,确认由本公司附属公司深圳市健心医疗科技有限公司与国家心血管病中心中国医学科学院阜外医院联合研发的LantvalTM主动脉瓣膜置换系统进入国家药品监督管理局创新医疗器械特别审查程序。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494794.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","GDOC","AGNG","BK1600","159883","KCAI","HART","BK4588","PTH","BK1100","LGHT","IEIH","RSPH","01302","BK1574","MEDX","09996","MDEV","BK4585","BK1583","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666127155","title":"【券商聚焦】中信建投:醫療器械板塊業績有望逐步改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2666127155","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666127155?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 09:18","pubTimestamp":1789089493,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究指,医疗器械板块Q2收入延续增长趋势,单季度利润增速四年来首次转正。该机构认为,随着集采影响逐步出清叠加创新驱动和海外业务加速的双重助力,医疗器械板块业绩有望逐步改善。尽管季度业绩增速可能有所波动,Q3能否相比Q2加速尚不确定,但大趋势来看,26和27年年度业绩持续改善的确定性较强。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991348","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0173614495.USD","BK1142","06826","02252","01066","01302","LU0287142896.SGD","PTH","BK1502","AGNG","BK1584","BK1593","BK1591","IEIH","BK1100","BK1617","BK1574","BK1600","BK1222","BK1585","RSPH","LNGR","BK1610","BK1589","HART","MEDX","BK1501","BK1571","MDEV","601066","BK1189","GDOC","02190","BK1161","159883","BK1587","BK0276","00241","BK1615","KCE","00853","BK1247","HK0000165453.HKD","LGHT","02235","BK1583","BK1515","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666983512","title":"深港攜手拓全球藥械市場,2026深圳國際高性能醫療器械展舉行","url":"https://stock-news.laohu8.com/highlight/detail?id=2666983512","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666983512?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 09:10","pubTimestamp":1789089045,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LNGR","LU0067412154.USD","00152","LGHT","IEIH","AGNG","159883","BK1574","BK1507","09996","BK1100","MEDX","LU1152091168.USD","BK1185","RSPH","SG9999003461.SGD","LU1152091754.HKD","HART","BK1582","BK1583","LU1008478684.HKD","MDEV","LU0880133367.SGD","GDOC","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666755282","title":"透景生命(300642.SZ)控股子公司申報醫療器械註冊獲得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2666755282","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666755282?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 11:50","pubTimestamp":1789012238,"startTime":"0","endTime":"0","summary":"智通财经APP讯,透景生命(300642.SZ)发布公告,公司控股子公司上海脉示生物技术有限公司申报的医疗器械注册申请于近日获得了上海市药品监督管理局的受理,产品名称:四项抗癫痫药物浓度测定试剂盒(液相色谱串联质谱法)。该产品用于检测人体血清样本中的丙戊酸、奥卡西平代谢物(10,11-二氢-10-羟基卡马西平)、托吡酯、左乙拉西坦浓度。临床上用于丙戊酸、奥卡西平代谢物(10,11-二氢-10-羟基卡马西平)、托吡酯、左乙拉西坦血药浓度的监测。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494298.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159883","IEIH","BK1583","PTH","BK0042","09996","MDEV","LNGR","BK1574","BK1100","AGNG","GDOC","300642","HART","MEDX","LGHT","BK0046","RSPH","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125046610","title":"直覺外科高管:海外系統租賃費率將隨時間逐步上調","url":"https://stock-news.laohu8.com/highlight/detail?id=1125046610","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125046610?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 21:18","pubTimestamp":1788959894,"startTime":"0","endTime":"0","summary":"在最新财报电话会议中,直觉外科公司的一位高管明确表示,公司预计其在美国以外地区的系统租赁费率将\"随时间推移而逐步攀升\"。这一表态透露出该公司对国际市场需求持续走强的信心。值得关注的是,这一预期中的费率调整并非短期行为,而是一个渐进式的长期过程。毕竟,租赁模式的费率调整,将直接作用于公司的经常性收入曲线,进而影响其长期估值逻辑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5TLWC47.USD","BK4504","LU2106854487.HKD","LU0390134368.USD","LU1868837300.USD","EKG","IE00BYQQ9H92.USD","LU1023059063.AUD","LU1804176565.USD","BK4534","LU0079474960.USD","ISUL","BK4082","LU2023250504.SGD","LU2063271972.USD","LU1868836757.USD","LU1868836591.USD","LU1974910355.USD","LU1923623000.USD","LU0823434740.USD","BK4588","ISRG","LGHT","LU1868837136.USD","LU1366192091.USD","LU2125909593.SGD","BK4585","LU0097036916.USD","LU0882574055.USD","IE00B19Z9505.USD","LU1951198990.SGD","IE00BFXG0V08.USD","LU2324357040.USD","LU0823416689.USD","LU1989764664.SGD","LU0823434583.USD","LU1923622614.USD","LU0289739699.SGD","LU0061475181.USD","IE00B19Z8W00.USD","LU2023250843.SGD","LU1989764748.USD","LU0058720904.USD","LU2265009873.SGD","LU1057294990.SGD","LU0238689110.USD","LU2112291526.USD","LU0354030438.USD","LU1983299246.USD","LU2125909247.SGD","LU1061106388.HKD","LU2433249047.HKD","LU0096364046.USD","LU0122379950.USD","LU1951200564.SGD","LU0114720955.EUR","BK4548","LU0354030511.USD","IE00B19Z8X17.USD","LU1917777945.USD","LU1868836914.USD","LU0432979614.USD","IHI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128809514","title":"直覺外科高管:美國減重手術僅佔全球達芬奇手術量逾2%,增量影響正逐步放緩——電話會議紀要","url":"https://stock-news.laohu8.com/highlight/detail?id=1128809514","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128809514?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 21:14","pubTimestamp":1788959649,"startTime":"0","endTime":"0","summary":"直觉外科公司(Intuitive Surgical)高管在电话会议中透露,美国减重手术在全球达芬奇手术总量中的占比略高于2%。值得注意的是,这一细分领域所带来的增量影响正随时间推移而逐渐减弱,其边际效应呈现出日益温和的态势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868836914.USD","LU0238689110.USD","LGHT","LU1917777945.USD","LU1989764664.SGD","IHI","LU1974910355.USD","IE00B19Z8W00.USD","LU1951200564.SGD","LU2125909247.SGD","IE00B19Z9505.USD","ISUL","LU2324357040.USD","LU0114720955.EUR","LU0122379950.USD","BK4548","BK4534","LU0097036916.USD","LU0061475181.USD","LU0289739699.SGD","BK4588","LU0432979614.USD","LU1868837300.USD","BK4585","LU0079474960.USD","LU1951198990.SGD","LU1983299246.USD","LU2106854487.HKD","LU0823434740.USD","LU2112291526.USD","ISRG","LU0096364046.USD","LU1868836591.USD","LU1061106388.HKD","LU0354030438.USD","LU0390134368.USD","LU1804176565.USD","LU0823416689.USD","LU0058720904.USD","EKG","IE00B5TLWC47.USD","BK4082","LU2433249047.HKD","IE00B19Z8X17.USD","LU0354030511.USD","LU1989764748.USD","LU2023250504.SGD","LU1057294990.SGD","LU1868836757.USD","BK4504","LU1923623000.USD","LU1023059063.AUD","LU1923622614.USD","LU2023250843.SGD","IE00BYQQ9H92.USD","LU0882574055.USD","LU2063271972.USD","LU2125909593.SGD","LU0823434583.USD","LU1868837136.USD","LU2265009873.SGD","IE00BFXG0V08.USD","LU1366192091.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}